The promise to the public: generic competition. Submission to the pharmaceutical patents review
Governments have agreed time-limited monopolies to encourage domestic invention through the grant of patents. At the end of the agreed period, the patented invention should be reproducible by skilled persons without undue experimentation and the new knowledge embodied in the invention should be freely available and usable by all. This paper presents evidence on delays to the entry of generic pharmaceuticals in Australia, then considers (briefly) the arguments put by "big pharma" in support of a...[Show more]
|Collections||ANU Research Publications|
|Source:||The Promise to the Public: Generic Competition (April 30, 2013). Available at SSRN: http://ssrn.com/abstract=2547374|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.